*Staphylococcus aureu*s infections are caused by methicillin-susceptible (MSSA) or methicillin-resistant (MRSA) strains.[@b1-asm-5-513],[@b2-asm-5-513] MRSA emerged in 1960 and was a problem confined largely to the healthcare setting, known as hospital-associated MRSA (HA-MRSA). In the late 1990s community-associated (acquired) MRSA (CA-MRSA) infections appeared in the United States and then emerged worldwide. CA-MRSA infections involve predominantly skin and soft tissue; however, severe infections have been described. [@b3-asm-5-513]--[@b7-asm-5-513] In Saudi Arabia, the prevalence MRSA has been increasing and severe community-acquired infections has been reported in the past 10 years.[@b8-asm-5-513]--[@b12-asm-5-513] In the current study we retrospectively analysed the staphylococcus isolates in the western region of Saudi Arabia.

METHODS
=======

The study was conducted at a university hospital in the western part of Saudi Arabia. Retrospectively, the medical records of patients who were diagnosed with *S aureus* infections were reviewed and data were extracted. The analysis included all isolates of *S aureus* collected from both outpatients and hospitalized patients. Patient-specific characteristics were collected, including age, sex, gender, a documented history of MRSA infection within the previous year, and hospitalization within the previous year.

The records of 186 *S aureus* infected patients diagnosed in the period between 1 November 2009 through 31 October 2010 were included in the study.

The microbiology laboratory had performed identification of *S aureus* based on colony morphology, Gram stain, catalase and coagulase tests. Susceptibility to oxacillin and cefoxitin was performed using oxacillin 1 μg disk and cefoxitin 30 μg disk according to the performance standards of the Clinical and Laboratory Standards Institute (CLSI).[@b13-asm-5-513] Susceptibility to trimethoprim/sulfmethoxazole, rifampicin, levofloxacin, erythromycin, clindamycin, tetracycline, vancomycin, linozolid, and teicoplanin of the isolates were conducted according to the CLSI standards by the clinical microbiology laboratory utilizing VITEK 2 (bio-Mérieux, Durham, North Carolina, United States).[@b13-asm-5-513] The chi-square test was used to evaluate the statistical significance of the observed differences in prevalence and susceptibility patterns of CA-MRSA compared HA-MRSA.

RESULTS
=======

Two hundred *S aureus* isolates from 186 patients in the study period were analysed. The demographic and clinical data of the patients were evaluated to assess the significance of different risk factors underlying the acquisition of MRSA both in the community and hospital. The patients included 95 males and 91 females. MSSA was isolated in 121 specimens from 121 patients. Of MSSA infections, 85 were community-acquired and 36 were acquired in hospitals. Seventy-nine MRSA isolates isolated from 65 patients were registered during the study period. Of the 65 MRSA isolates, 39 were community-acquired and 40 were acquired in hospital in patients with no history of hospitalization in the previous year. The total *S aureus* infections acquired in the community were 124 of which 39 were MRSA (31.5%), while the total hospital isolates were 76; of these 40 were MRSA (52.6%). The proportion of MRSA infection out of the total *S aureus* infection was found to be significantly higher in the hospital (*P*=.0029) ([Figure 1](#f1-asm-5-513){ref-type="fig"}). Patients from different age groups were diagnosed during the study period. The prevalence of MRSA was significantly higher among patients who were 56 years old or older (52.2%) ([Figure 2](#f2-asm-5-513){ref-type="fig"}).

All MRSA isolates in our study were susceptible in vitro to vancomycin, linozolid and teicoplanin. Resistance to other tested antibiotics was variable with significantly higher resistance to levofloxacin, erythromycin, and clindamycin among HAMRSA isolates compared to CA-MRSA ([Table 1](#t1-asm-5-513){ref-type="table"}). Resistance to four or more antibiotics was observed in 29.1% of the isolates and was significantly higher among HA-MRSA (*P*=.03). The most common infections caused by MRSA, both in hospitals and the community were wound, skin and soft tissue infections (87.3%), followed by pneumonia (5.1%) ([Figure 3](#f3-asm-5-513){ref-type="fig"}). Co-morbidity was documented in 37/121 MSSA, and 20/79 MRSA (*P*=.42). Diabetes mellitus was the most common documented co-morbidity (45.9% of MSSA, 50.0% of MRSA).

DISCUSSION
==========

In our study, 79 MRSA isolates were identified. The detection of MRSA was performed using the combination of oxacillin and cefoxitin disks. The use these disks in detection of MRSA has been shown in a number of studies to be highly sensitive and specific. Some studies have even proposed the use of these disks as a good substitute for PCR for the mecA gene.[@b14-asm-5-513]--[@b17-asm-5-513]

Our results showed that the highest prevalence of MRSA is among old patients aged 56 years old or older. Previous studies demonstrated variable distribution of MRSA in the different age groups. A Saudi study showed MRSA to be most prevalent in the extremes of age.[@b18-asm-5-513] An American study reported a pattern of decreasing age during a period of ten years observation while another American study, which was conducted about the same time, showed that the greatest MRSA rate increase was for individuals 17 years and younger. [@b19-asm-5-513],[@b20-asm-5-513] These observations may indicate a changing pattern which may be explained by the different causative strains that have different virulence determinants.

The antibiotic susceptibility pattern observed in our study is in accordance with previous studies. All MRSA isolates in the current study were susceptible to vancomycin, linezolid and teicoplanin. Similar results were demonstrated in several other studies.[@b21-asm-5-513],[@b22-asm-5-513] Resistance to tetracycline, rifampicin, trimethoprim/sulfamethoxazole, levofloxacin, erythromycin, and clindamycin was variable. Resistance to four or more antibiotics was significantly higher in HA-MRSA and so was resistance to levofloxacin, erythromycin and clindamycin. Similar patterns of resistance were shown by Al-Twafiq and Jung et al.[@b8-asm-5-513],[@b23-asm-5-513] This pattern of resistance may indicate the presence of staphylococcal cassette chromosome mec (SCCmec) --II in our HA-MRSA isolates as indicated by Kilic et al.[@b24-asm-5-513] CA-MRSA were fairly susceptible to trimethoprim/sulfamethoxazole and rifampicin which may be good treatment options for these infections. However, rifampicin may be reserved for use in combination therapy to guard against the emergence of resistance to this antibiotic as it is still needed in treatment of infections like TB. The most common infections caused by MRSA were skin, soft tissue, and wound infections; this preponderance is well documented in a number of studies.[@b25-asm-5-513],[@b26-asm-5-513] Few other MRSA infections such as pneumonia, joint infections, sinusitis, and catheter-associated infections were reported in this study. The outcome of MRSA infections in the current study was not evaluated because there were no complete data. About one-third of MRSA were multidrug-resistant and HA-MRSA were significantly more resistant, especially to levofloxacin, erythromycin, and clindamycin, which may point to excessive use of these antibiotics in hospitals.
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###### 

In vitro antibiotic susceptibilities of MRSA isolates.

  Variable                       Total tested   Resistant isolates   Percent of resistant isolates (%)   Proportion   *P*
  ------------------------------ -------------- -------------------- ----------------------------------- ------------ --------
  Trimethoprim/sulfmethoxazole                                                                                        
   CA                            32             7                    22                                  0.218        0.0711
   HA                            39             16                   41                                  0.41         
  Refampicin                                                                                                          
   CA                            27             5                    18.5                                0.185        0.0924
   HA                            35             13                   37.1                                0.371        
  Levofloxacin                                                                                                        
   CA                            27             9                    33.3                                0.333        0.0118
   HA                            30             20                   66.7                                0.666        
  Erythromycin                                                                                                        
   CA                            28             15                   53.6                                0.535        0.0259
   HA                            36             28                   77.8                                0.777        
  Clindamycin                                                                                                         
   CA                            36             17                   47.2                                0.472        0.0178
   HA                            38             28                   73.7                                0.736        
  Tetracycline                                                                                                        
   CA                            30             15                   50.0                                0.500        0.092
   HA                            34             24                   70.6                                0.705        

CA: community acquired; HA: hospital acquired
